800.850.4306

Medication List
How to Prescribe

Precigen Selects McKesson to Support Specialty Pharmacy and Patient Hub Services for Launch of Novel Immunotherapy

  • Biologics by McKesson, in partnership with InspiroGene by McKesson, was chosen as the exclusive specialty pharmacy for a newly approved immunotherapy for adults with recurrent respiratory papillomatosis.

InspiroGene by McKesson Selected as the Specialty Pharmacy Partner for Iovance’s Amtagvi®—First Cell Therapy Approved for Solid Tumors

  • Biologics by McKesson, in partnership with InspiroGene, supports Amtagvi, the first FDA-approved one-time cell therapy for a solid tumor in patients with unresectable or metastatic melanoma.

WAYRILZ™ (rilzabrutinib), FDA-Approved for Treatment of Adults with Immune Thrombocytopenia, Available at Biologics by McKesson

  • Biologics by McKesson was selected as a limited specialty pharmacy provider for WAYRILZ, an oral BTK inhibitor for adults with persistent or chronic immune thrombocytopenia.

PIQRAY® (alpelisib) FDA Approved for the Treatment of Patients with a PIK3CA Mutation in HR+/HER2- Advanced Breast Cancer , Available Exclusively at Biologics by McKesson

  • Biologics by McKesson became the exclusive specialty pharmacy for PIQRAY, indicated with fulvestrant for adults with PIK3CA-mutated, HR-positive, HER2-negative advanced or metastatic breast cancer.

VIJOICE® (alpelisib) FDA Approved for the Treatment of Patients with PIK3CA-Related Overgrowth Spectrum (PROS), Available Exclusively at Biologics by McKesson

  • Biologics by McKesson became the exclusive specialty pharmacy for VIJOICE, indicated for adults and children age 2 and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum.

ENSACOVE™ (ensartinib), FDA-Approved Treatment for Adult Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer, Exclusively Available at Biologics by McKesson

  • Biologics by McKesson became the sole specialty pharmacy provider for ENSACOVE and exclusive hub services provider for adults with advanced ALK-positive non-small cell lung cancer.
Load More